[Medico-economic evaluation of the PRADO-BPCO post-exacerbation support program]

Area of Science:

• Pulmonary Medicine
• Health Services Research
• Health Economics

Context:

• Hospitalized COPD exacerbations necessitate structured post-discharge care.
• The Programme d'Accompagnement du retour à Domicile (PRADO) COPD is a home discharge support program.
• Assessing the medico-economic impact of PRADO COPD is crucial for healthcare system optimization.

Purpose:

• To evaluate the medico-economic impact of the PRADO COPD program.
• To compare outcomes between patients in the PRADO COPD program and a matched control group.
• To analyze the effect of PRADO COPD on mortality, rehospitalization, and healthcare costs.

Summary:

• A retrospective study analyzed PRADO COPD patients (2017-2019) using National Health Data System data.
• Propensity score matching created a control group to compare 12-month post-hospitalization outcomes.
• PRADO COPD improved adherence to care recommendations but did not significantly impact overall mortality or rehospitalization rates.

Impact:

• The PRADO COPD program enhances the quality of patient care pathways.
• A significant reduction in rehospitalization rates was observed for PRADO patients with optimal care pathways.
• Healthcare costs were higher by €670 per patient in the PRADO group, indicating a trade-off between quality and cost.